Logo image of KDA.CA

KDA GROUP INC (KDA.CA) Stock Fundamental Analysis

TSX-V:KDA - TSX Venture Exchange - CA48669F1071 - Common Stock - Currency: CAD

0.295  +0.03 (+13.46%)

Fundamental Rating

2

Overall KDA gets a fundamental rating of 2 out of 10. We evaluated KDA against 17 industry peers in the Health Care Providers & Services industry. While KDA seems to be doing ok healthwise, there are quite some concerns on its profitability. KDA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KDA had negative earnings in the past year.
KDA had a negative operating cash flow in the past year.
In multiple years KDA reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: KDA reported negative operating cash flow in multiple years.
KDA.CA Yearly Net Income VS EBIT VS OCF VS FCFKDA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

KDA has a worse Return On Assets (-51.57%) than 75.00% of its industry peers.
KDA has a worse Return On Equity (-55.28%) than 62.50% of its industry peers.
Industry RankSector Rank
ROA -51.57%
ROE -55.28%
ROIC N/A
ROA(3y)2.11%
ROA(5y)-2.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KDA.CA Yearly ROA, ROE, ROICKDA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

KDA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KDA.CA Yearly Profit, Operating, Gross MarginsKDA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K

More info and screens

6

2. Health

2.1 Basic Checks

KDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
KDA has more shares outstanding than it did 1 year ago.
KDA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, KDA has an improved debt to assets ratio.
KDA.CA Yearly Shares OutstandingKDA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
KDA.CA Yearly Total Debt VS Total AssetsKDA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

KDA has an Altman-Z score of 32.85. This indicates that KDA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 32.85, KDA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that KDA is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.06, KDA belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 32.85
ROIC/WACCN/A
WACC7.63%
KDA.CA Yearly LT Debt VS Equity VS FCFKDA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 2.50 indicates that KDA has no problem at all paying its short term obligations.
KDA's Current ratio of 2.50 is amongst the best of the industry. KDA outperforms 100.00% of its industry peers.
A Quick Ratio of 2.50 indicates that KDA has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.50, KDA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.5
KDA.CA Yearly Current Assets VS Current LiabilitesKDA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

KDA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -171.32%.
The Revenue for KDA has decreased by -19.06% in the past year. This is quite bad
KDA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -63.61% yearly.
EPS 1Y (TTM)-171.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.4%
Revenue 1Y (TTM)-19.06%
Revenue growth 3Y-81.78%
Revenue growth 5Y-63.61%
Sales Q2Q%18.28%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KDA.CA Yearly Revenue VS EstimatesKDA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KDA.CA Yearly EPS VS EstimatesKDA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KDA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KDA.CA Price Earnings VS Forward Price EarningsKDA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KDA.CA Per share dataKDA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KDA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KDA GROUP INC

TSX-V:KDA (2/21/2025, 7:00:00 PM)

0.295

+0.03 (+13.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)12-17 2024-12-17
Earnings (Next)03-20 2025-03-20
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.72%
Ins Owner ChangeN/A
Market Cap54.49M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 369.6
P/FCF N/A
P/OCF N/A
P/B 4.36
P/tB 42.74
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.07
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.57%
ROE -55.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.11%
ROA(5y)-2.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 65.43%
Cap/Sales 1424.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 2.5
Altman-Z 32.85
F-Score2
WACC7.63%
ROIC/WACCN/A
Cap/Depr(3y)390.74%
Cap/Depr(5y)342.39%
Cap/Sales(3y)1339.01%
Cap/Sales(5y)805.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-171.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.06%
Revenue growth 3Y-81.78%
Revenue growth 5Y-63.61%
Sales Q2Q%18.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-72.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-123.76%
OCF growth 3YN/A
OCF growth 5YN/A